Abstract
A series of hydroxyethylamines has been synthesized from the reaction of (2S,3S )Boc-phenylalanine epoxide with alkyl amines in good yields and evaluated for their in vivo antimalarial activity in mice. Compound 4g presented better activity then the reference artesunate in percentage of inhibition of parasitemia in treated P. berghei-infected mice and compare to the activity of artesunate in the survival of mice 14 days after infection. In addiction, no hemolytic activity was found, which supports that inhibition of parasitemia is due to antimalarial activity. The compound 4g inhibited the differentiation to schizonts suggesting that parasite metabolism is a possible target of 4g. These results indicate that this class of compound possesses promising perspectives for the development of new antimalarial drugs.
Keywords: Hydroxyethylamine, antimalarial drugs, protease inhibitors, plasmepsin, inhibition, Malaria, diseases, Plasmodium, antimalarials, life cycle
Medicinal Chemistry
Title:Synthesis and In Vivo Antimalarial Evaluation of Novel Hydroxyethylamine Derivatives
Volume: 8 Issue: 2
Author(s): Mariana Conceicao de Souza, Triciana Goncalves-Silva, Marcele Moreth, Claudia R.B. Gomes and Carlos Roland Kaiser, Maria das Gracas Muller de Oliveira Henriques, Marcus V.N. de Souza
Affiliation:
Keywords: Hydroxyethylamine, antimalarial drugs, protease inhibitors, plasmepsin, inhibition, Malaria, diseases, Plasmodium, antimalarials, life cycle
Abstract: A series of hydroxyethylamines has been synthesized from the reaction of (2S,3S )Boc-phenylalanine epoxide with alkyl amines in good yields and evaluated for their in vivo antimalarial activity in mice. Compound 4g presented better activity then the reference artesunate in percentage of inhibition of parasitemia in treated P. berghei-infected mice and compare to the activity of artesunate in the survival of mice 14 days after infection. In addiction, no hemolytic activity was found, which supports that inhibition of parasitemia is due to antimalarial activity. The compound 4g inhibited the differentiation to schizonts suggesting that parasite metabolism is a possible target of 4g. These results indicate that this class of compound possesses promising perspectives for the development of new antimalarial drugs.
Export Options
About this article
Cite this article as:
Mariana Conceicao de Souza, Triciana Goncalves-Silva, Marcele Moreth, Claudia R.B. Gomes and Carlos Roland Kaiser, Maria das Gracas Muller de Oliveira Henriques, Marcus V.N. de Souza , Synthesis and In Vivo Antimalarial Evaluation of Novel Hydroxyethylamine Derivatives , Medicinal Chemistry 2012; 8 (2) . https://dx.doi.org/10.2174/157340612800493638
DOI https://dx.doi.org/10.2174/157340612800493638 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Near-infrared Light Activatable Multimodal Gold Nanostructures Platform: An Emerging Paradigm for Cancer Therapy
Current Cancer Drug Targets The Metabolic Syndrome and the Relevance of Nutrients for its Onset
Recent Patents on Biotechnology Neuroprotective Strategies in Glaucoma
Current Pharmaceutical Design Leukocyte-Endothelial Cell Interactions: A Therapeutic Target to Ameliorate Inflammatory Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Medicinal Chemistry of Novel Iron Chelators for the Treatment of Cancer
Current Topics in Medicinal Chemistry Current Issues in Intravenous Fluid Use in Hospitalized Children
Reviews on Recent Clinical Trials Sorafenib (BAY 43-9006): Review of Clinical Development
Current Clinical Pharmacology How Do Microbubbles and Ultrasound Interact? Basic Physical, Dynamic and Engineering Principles
Current Pharmaceutical Design Medical Treatment of Aortic Aneurysms in Marfan Syndrome and other Heritable Conditions
Current Cardiology Reviews Inhibitors of Nitric Oxide Synthase: What's up and What's Next?
Current Enzyme Inhibition Phosphodiesterase Type 5 Inhibitors for the Management of Erectile Dysfunction: Preference and Adherence to Treatment
Current Pharmaceutical Design Sustained ELABELA Gene Therapy in High-salt Diet-induced Hypertensive Rats
Current Gene Therapy Regulation of Platelet Function by Acetylation/Deacetylation Mechanisms
Current Medicinal Chemistry Stem Cell Therapy in Chronic Ischemic Heart Dysfunction with and Without Viability
Cardiovascular & Hematological Disorders-Drug Targets Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy
Current Gene Therapy Bioactive Coatings for Minimally Invasive Medical Devices: Surface Modification in the Service of Medicine
Recent Patents on Biomedical Engineering (Discontinued) The DOCA-Salt Hypertensive Rat as a Model of Cardiovascular Oxidative and Inflammatory Stress
Current Cardiology Reviews CA125: An Increasingly Promising Biomarker of Heart Failure
Current Pharmaceutical Design Mevalonate Cascade and Small Rho GTPase in Spinal Cord Injury
Current Molecular Pharmacology Antithrombotic Treatment in the Prevention of Ischemic Stroke
Current Drug Targets